Annual D&A
$4.98B$1.72B+52.74%
Summary
- Current Value
- As of today, GSK annual D&A is $4.98B, up +52.74% on
- Historical Performance
- GSK annual D&A is up +88.27% over the past 3 years, and up +65.15% over the past 5 years
- All-Time High Comparison
- GSK annual D&A is currently at its all-time high
- 3-Year Low Comparison
- GSK annual D&A is +88.27% above its 3-year low of $2.64B reached on an earlier date
- Sector Comparison
- GSK annual D&A is higher than 99.73% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $4.98B | +52.7% | +88.3% | +65.2% | +92.1% | |
| Quarterly D&A | $1.39B | +21.9% | +1960.3% | -59.5% | +361.8% | |
| TTM D&A | $5.00B | +29.8% | +78.1% | +65.9% | +92.8% | |
| Price | $58.48 | +60.4% | +63.2% | +61.4% | +50.4% | |
| Annual SG&A | $11.98B | +4633.9% | +4964.2% | +2189.2% | -40.5% | |
| Annual Total Expenses | $35.52B | -3.5% | +16.0% | -2.3% | -14.0% | |
| Annual Operating Expenses | $21.78B | +5.0% | +38.4% | +13.7% | -10.1% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.98B | at high | |
| 5Y | $4.98B | at high | |
| All | $4.98B | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.64B | N/A | +88.3% |
| 5Y | $2.64B | +88.3% | |
| All | $279.40M | +1682.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of GSK?
As of today, GSK annual D&A is $4.98B
What is 1-year change in GSK annual D&A?
GSK annual D&A is up +52.74% year-over-year
What is 3-year change in GSK annual D&A?
GSK annual D&A is up +88.27% over the past 3 years
How far is GSK annual D&A from its all-time high?
GSK annual D&A is currently at its all-time high
How does GSK annual D&A rank versus sector peers?
GSK annual D&A is higher than 99.73% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly D&A
$1.39B$339.87M+32.41%
Summary
- Current Value
- As of today, GSK quarterly D&A is $1.39B, up +32.41% on
- Historical Performance
- GSK quarterly D&A is up +21.93% year-over-year, and up +1960.34% over the past 3 years
- All-Time High Comparison
- GSK quarterly D&A is currently -59.48% below its historical high of $3.43B set on
- 3-Year Low Comparison
- GSK quarterly D&A is +1960.34% above its 3-year low of -$74.64M reached on an earlier date
- Sector Comparison
- GSK quarterly D&A is higher than 99.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.39B | +32.4% | +21.9% | +1960.3% | -59.5% | |
| Annual D&A | $4.98B | – | +52.7% | +88.3% | +65.2% | |
| TTM D&A | $5.00B | +5.3% | +29.8% | +78.1% | +65.9% | |
| Price | $58.48 | +23.5% | +60.4% | +63.2% | +61.4% | |
| Quarterly SG&A | $3.51B | +16.2% | +2.8% | +22.7% | -15.9% | |
| Quarterly Total Expenses | $10.62B | +20.5% | +7.5% | +54.0% | -0.3% | |
| Quarterly Operating Expenses | $6.67B | +32.3% | +16.6% | +34.9% | +17.1% | |
| Quarterly Revenue | $11.46B | -0.6% | +10.2% | +32.5% | -0.7% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.52B | -8.9% | |
| 3Y | $1.52B | -8.9% | |
| 5Y | $3.43B | N/A | -59.5% |
| All | $3.43B | -59.5% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.04B | +34.0% | |
| 3Y | -$74.64M | N/A | +1960.3% |
| 5Y | -$74.64M | +1960.3% | |
| All | -$1.47B | +194.5% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of GSK?
As of today, GSK quarterly D&A is $1.39B
What is GSK quarterly D&A most recent change?
GSK quarterly D&A was up +32.41% on December 31, 2025
What is 1-year change in GSK quarterly D&A?
GSK quarterly D&A is up +21.93% year-over-year
How far is GSK quarterly D&A from its all-time high?
GSK quarterly D&A is currently -59.48% below its historical high of $3.43B set on December 31, 2020
How does GSK quarterly D&A rank versus sector peers?
GSK quarterly D&A is higher than 99.80% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM D&A
$5.00B$249.80M+5.26%
Summary
- Current Value
- As of today, GSK TTM D&A is $5.00B, up +5.26% on
- Historical Performance
- GSK TTM D&A is up +29.76% year-over-year, and up +78.07% over the past 3 years
- All-Time High Comparison
- GSK TTM D&A is currently -16.01% below its historical high of $5.95B set on
- 3-Year Low Comparison
- GSK TTM D&A is +147.33% above its 3-year low of $2.02B reached on
- Sector Comparison
- GSK TTM D&A is higher than 99.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $5.00B | +5.3% | +29.8% | +78.1% | +65.9% | |
| Annual D&A | $4.98B | – | +52.7% | +88.3% | +65.2% | |
| Quarterly D&A | $1.39B | +32.4% | +21.9% | +1960.3% | -59.5% | |
| Price | $58.48 | +23.5% | +60.4% | +63.2% | +61.4% | |
| TTM SG&A | $49.99B | +320.2% | +254.3% | +385.5% | +239.8% | |
| TTM Revenue | $43.11B | +2.5% | +7.5% | +19.1% | -1.5% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.00B | at high | |
| 3Y | $5.00B | at high | |
| 5Y | $5.95B | -16.0% | |
| All | $5.95B | -16.0% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.85B | N/A | +29.8% |
| 3Y | $2.02B | +147.3% | |
| 5Y | $2.02B | +147.3% | |
| All | -$826.51M | +704.7% |
TTM D&A History
FAQ
What is the current TTM D&A of GSK?
As of today, GSK TTM D&A is $5.00B
What is GSK TTM D&A most recent change?
GSK TTM D&A was up +5.26% on December 31, 2025
What is 1-year change in GSK TTM D&A?
GSK TTM D&A is up +29.76% year-over-year
How far is GSK TTM D&A from its all-time high?
GSK TTM D&A is currently -16.01% below its historical high of $5.95B set on September 30, 2021
How does GSK TTM D&A rank versus sector peers?
GSK TTM D&A is higher than 99.90% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk